Comprehensive B-cell Subtype Analysis (CD21 and CD19 Flow Cytometry)
This test measures specific markers (CD21 and CD19) on B-cells in your blood to help identify and characterize different types of B-cells, often used in diagnosing and monitoring conditions like lymphoma or immune disorders.
["This test helps doctors understand your immune system’s B-cell activity and potential abnormalities."]
Key facts at a glance
- LOINC
- 94754-9
- Short code
- CD21L38N
- Synonyms
- CD21low38- Cells/Cells.CD19 NFr Bld
- Category
- chemistry
- Sample
- whole-blood
- Container
- Lavender-top (EDTA) or sodium heparin tube; ACD tube also acceptable for flow cytometry
- Units
- N/A
- Ref low
- 2
- Ref high
- 10
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 0–99 years
- Method
- Flow cytometry using fluorescently labeled monoclonal antibodies (CD19, CD21, CD38) with multiparameter immunophenotyping
- CPT
- 88184
- SNOMED
- 395145001
- Specimen volume
- 3-5 mL whole blood (minimum 1 mL for pediatric samples)
- Stability
- Specimen should be processed within 24-48 hours of collection at room temperature (18-25°C). Do not refrigerate if processing will be delayed more than 24 hours; keep at room temperature
- Hemolysis max
- 0
- Lipemia max
- 0
- Icterus max
- 0
- TAT
- 4–48 hours
- Order
- routine
Why This Test Is Done
Doctors may order this test if you have symptoms like persistent fatigue, unexplained weight loss, swollen lymph nodes, or if they suspect conditions like chronic lymphocytic leukemia (CLL), non-Hodgkin lymphoma, or other immune-related diseases. It can also be part of monitoring treatment progress.
What to Expect Before the Test
No special preparation is needed. You’ll have a small needle inserted into a vein (usually in your arm), and a small amount of blood will be drawn. The process takes about 5 minutes, and you may feel a brief pinch. The blood sample is then analyzed in a lab to detect specific cell markers.
What the Results Mean
The test identifies the presence and proportion of B-cells expressing CD21 and CD19 markers. Abnormal levels or patterns may indicate conditions affecting B-cell function or proliferation, such as certain cancers or immune deficiencies. Your doctor will interpret the results in the context of your symptoms and medical history.
Common Conditions This Test Helps Diagnose
This test is often used to diagnose or monitor conditions like chronic lymphocytic leukemia (CLL), non-Hodgkin lymphoma, Waldenström macroglobulinemia, and other B-cell-related disorders. It may also help assess immune system health in patients with autoimmune diseases or after stem cell transplants.
Reference range
CD21lowCD38- B cells as a percentage of total CD19+ B cells in peripheral blood; reference values vary by laboratory. Typical adult reference range: 2-10% of CD19+ B cellsN/A
No special preparation required. Avoid recent immunosuppressant therapy if clinically feasible, as it may affect lymphocyte subset distribution
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Clinical Significance: How Results Impact Treatment
Short name
B-cell Immunophenotyping
Frequently asked questions
What does a low count of CD21+ B-cells mean?
Can this test detect early signs of lymphoma?
How often should I get this test if I have a known condition?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy